Oxford says identification of blood clots linked to vaccine shows safety system works

FILE PHOTO: Empty vials of Oxford/AstraZeneca's COVID-19 vaccine are seen at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman/File Photo

LONDON (Reuters) - Oxford University on Wednesday said that the identification of rare blood clots that might be linked to its COVID-19 vaccine showed safety systems worked, emphasising that British and European regulators had found its benefits outweigh the risks.

"We are reassured to see that safety monitoring continues under the close scrutiny of regulators... The identification of rare cases of blood clots, which might be associated with the vaccine, shows that the safety system works," Andrew Pollard, director of the Oxford Vaccine Group, said of the reviews into the shot, developed with AstraZeneca

"(The system) has also allowed MHRA and EMA to conclude that the benefits of vaccination continue to outweigh the risks, while putting in measures to help mitigate any possible risk."

(Reporting by Alistair Smout)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Next In World

Hungary to widen services activity as vaccination rate nears 40%
Regional NGOs urge ASEAN to include ousted Myanmar lawmakers in crisis summit
Duterte's daughter stays top in poll on Philippine president candidates
Russia scrambles fighter jet to accompany U.S. spy plane: Interfax
NASA-SpaceX set to launch next 4-member crew to International Space Station
Biden's climate summit zeroes in on technology to help fight global warming
India posts world record daily Covid-19 cases for second straight day
South Korea widens public access to virus self-test kits amid surge
Indian coronavirus cases surge again as health system founders
Desperate hunt for missing Indonesian submarine as oxygen set to run out

Stories You'll Enjoy